SubHero Banner
Text

June 2023

Core topics in this month’s edition include:

  • Roctavian (valoctocogene roxaparvovec-rvox) – new drug approval
  • Leqembi (lecanemab-irmb) – FDA Advisory Committee update
  • Elevidys (delandistrogene moxeparvovec-rokl) – new orphan drug approval

Download PDF

Text